Literature DB >> 15040043

Risk factors influencing recurrence following resection of pancreatic head cancer.

De-Qing Mu1, Shu-You Peng, Guo-Feng Wang.   

Abstract

AIM: Whether operative procedure is a risk factor influencing recurrence following resection of carcinoma in the head of pancreas or not remains controversies. In this text we compared the recurrence rate of two operative procedure: the Whipple procedure and extended radical operation, and inquired into the factors influencing recurrence after radical resection.
METHODS: From January 1995 to December 1998, 35 cases of carcinoma of pancreas underwent the Whipple operadure, 21 patients received the Extended radical operation. All patients were followed up for more than 3 years. Prognostic factors included operative procedure, size of tumor, lymph node, interstitial invasion.
RESULTS: Deaths duo to recurrence within 3 years after operation were studied. The death rate was 51.4% in the Whipple procedure and 42.9% in the Extended radical operative procedure. There was a significant difference between the two groups. Recurrence occurred in 75% patients with tumor large than 4 cm, in 87.5% patients with lymph node involvement, and in 50% patients with the presence of interstitial invasion.
CONCLUSION: Tumor exceeding 4 cm, lymph node involvement, and presence of interstitial invasion are high risk factors of recurrence after Whipple's procedure and extended radical operation.

Entities:  

Mesh:

Year:  2004        PMID: 15040043      PMCID: PMC4727020          DOI: 10.3748/wjg.v10.i6.906

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Clinical and biological features of t1 ductal adenocarcinoma of the pancreas.

Authors:  S Takao; H Shinchi; K Sha; S Natsugoe; S Maenohara; T Suenaga; Y Nishimata; T Aikou
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

2.  Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.

Authors:  W Meyer; C Jurowich; M Reichel; B Steinhäuser; P H Wünsch; C Gebhardt
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

Review 3.  General aspects of surgical treatment of pancreatic cancer.

Authors:  S Pedrazzoli; C Pasquali; C Sperti
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

4.  Intermediate results of extended pancreaticoduodenectomy. Verona experience.

Authors:  C Iacono; E Facci; L Bortolasi; G Zamboni; A Scarpa; G Talamini; G Prati; F Nifosí; G Serio
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

5.  The role of extended radical operation for pancreatic cancer.

Authors:  A Nakao; T Kaneko; S Takeda; S Inoue; A Harada; S Nomoto; T Ekmel; K Yamashita; T Hatsuno
Journal:  Hepatogastroenterology       Date:  2001 Jul-Aug

6.  Prognostic factors in the operative treatment of ductal pancreatic carcinoma.

Authors:  C Gebhardt; W Meyer; M Reichel; P H Wünsch
Journal:  Langenbecks Arch Surg       Date:  2000-01       Impact factor: 3.445

7.  Patterns of failure after curative resection of pancreatic carcinoma.

Authors:  J F Griffin; S R Smalley; W Jewell; J C Paradelo; R D Reymond; R E Hassanein; R G Evans
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

8.  Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil.

Authors:  M L Foo; L L Gunderson; D M Nagorney; D C McLlrath; J A van Heerden; J S Robinow; L K Kvols; G R Garton; J A Martenson; S S Cha
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-06-15       Impact factor: 7.038

9.  Results of extensive surgery for pancreatic carcinoma.

Authors:  T Nagakawa; M Nagamori; F Futakami; Y Tsukioka; M Kayahara; T Ohta; K Ueno; I Miyazaki
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860

10.  Combination of intraoperative radiation with resection of cancer of the pancreas.

Authors:  T Hiraoka; R Uchino; K Kanemitsu; M Toyonaga; N Saitoh; I Nakamura; S Tashiro; Y Miyauchi
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov
View more
  7 in total

Review 1.  Intraoperative assessment of the Whipple resection specimen.

Authors:  Mahmoud A Khalifa
Journal:  J Clin Pathol       Date:  2007-03-16       Impact factor: 3.411

2.  The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz?

Authors:  Adriana C Gamboa; Mohammad Y Zaidi; Rachel M Lee; Juan M Sarmiento; David A Kooby; Maria C Russell; Kenneth Cardona; Shishir K Maithel
Journal:  J Gastrointest Surg       Date:  2019-08-29       Impact factor: 3.452

3.  Hematemesis as the initial complication of pancreatic adenocarcinoma directly invading the duodenum: a case report.

Authors:  Yueh-Hung Lin; Chih-Yen Chen; Chih-Ping Chen; Tien-Yin Kuo; Full-Young Chang; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

4.  Survival in resectable pancreatic ductal adenocarcinoma with para-aortic lymph node dissection: A retrospective study in Vietnamese population.

Authors:  Lan Thi Nguyen; Hung Van Nguyen; Dang Hai Do; Khiem Thanh Nguyen; Anh Tuan Do; Ha Hoang Pham; Chinh Duc Nguyen
Journal:  Ann Med Surg (Lond)       Date:  2021-05-01

5.  Current and emerging therapies for the treatment of pancreatic cancer.

Authors:  Rebecca A Moss; Clifton Lee
Journal:  Onco Targets Ther       Date:  2010-09-07       Impact factor: 4.147

6.  Recurrence and Prognostic Value of Circulating Tumor Cells in Resectable Pancreatic Head Cancer: A Single Center Retrospective Study.

Authors:  Qiao Zhang; Feng Xia; Qiang Sun; Wenjing Cao; Ali Mo; Weiming He; Jiazhen Chen; Weiqiao Zhang; Weiqiang Chen
Journal:  Front Surg       Date:  2022-04-06

7.  How to treat intestinal obstruction due to malignant recurrence after Whipple's resection for pancreatic head cancer: Description of 2 new endoscopic techniques.

Authors:  Christina Mouradides; Alaa Taha; Ivan Borbath; Pierre H Deprez; Tom G Moreels
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.